Empowering Global Precision Diagnostics: Rejing Bio Welcomes In Vitro Diagnostic Manufacturers for OEM Collaboration

In the rapidly developing field of in vitro diagnostics, laboratories, distributors, and healthcare providers worldwide are seeking reliable, innovative, and cost-effective solutions.

Beijing Hotgen Biotech Co., Ltd., established in 2005, is a biotech high-tech enterprise committed to the firm mission of "developing biotechnology to benefit human health." Hotgen Biotech empowers global partners by combining cutting-edge research and development, advanced manufacturing capabilities, and a comprehensive product portfolio.

Hotgen Biotech's expertise covers multiple in vitro diagnostic technology platforms, including chemiluminescence immunoassay technology, upconversion luminescence technology, among others.

With over 18,000 units deployed in more than 50 countries, EU certification, ISO certification, National Medical Products Administration certification, and a strong record of innovation including national awards and patents, Hotgen Biotech supports original equipment manufacturer partners in providing high-quality diagnostic solutions to meet diverse market needs.

Hotgen Biotech's Innovative Technology Platforms: The Foundation for Original Manufacturer Success

Hotgen Biotech excels in fully automated chemiluminescence immunoassay analyzers and related systems, offering flexible solutions for single-sample testing and high-throughput applications.

Single-Sample Chemiluminescence Immunoassay Analyzers (MQ60 Series)

The MQ60 Intelligent and MQ60 Professional are compact fully automated desktop systems designed for high efficiency in small to medium-sized laboratories.

These chemiluminescence immunoassay analyzers support serum, plasma, whole blood, and urine samples, with a testing throughput of 30 to 60 tests per hour.

Features include an integrated computer, touchscreen, laboratory information system/hospital information system connectivity, and reliable performance capable of testing over 130 parameters covering thyroid function, hormones, inflammation, cardiac markers, tumors, and more.

With a small footprint and easy operation, they are ideal for on-site or decentralized testing.

Fully Automated Chemiluminescence Immunoassay Systems (C800 and C2100)

For higher testing volume needs, the C800 achieves 150 tests per hour on just 0.4 square meters of space, with 30 sample positions, 17-minute rapid first result, and direct use of original blood collection tubes.

The C2100 further expands testing capacity.

These fully automated chemiluminescence immunoassay analyzers minimize manual intervention, reduce error rates, and support continuous operation, making them ideal for hospital laboratories requiring scalable fully automated immunoassay systems.

Upconversion Luminescence Point-of-Care Testing Technology (UPT2800)

Hotgen Biotech's independently developed upconversion luminescence technology represents a significant breakthrough in the field of point-of-care testing.

The UPT2800 analyzer provides quantitative results in seconds, with stability for room temperature storage and transportation, applicable to infectious diseases (including tuberculosis infection interferon release tests), cardiac diseases, inflammation, and more.

As one of China's award-winning upconversion luminescence platforms, its signal-to-noise ratio and stability outperform traditional fluorescence methods, making it highly attractive in emerging markets and resource-limited areas.

Rich Reagent Product System

In addition to instruments, Hotgen Biotech offers a wide range of reagent products, including:

• Chemiluminescence immunoassay reagents

• Upconversion luminescence assay reagents

• Enzyme-linked immunoassay reagents

• Colloidal gold rapid test reagents

• Tuberculosis-specific tests (tuberculosis infection interferon release tests)

• Gastric function markers (gastrin 17, pepsinogen I/II)

• Cytokine detection

• Hormone detection

This end-to-end capability enables original equipment manufacturer partners to combine instruments with matching consumables into a complete solution, achieving a seamless and high-performance testing system.

Why Choose Hotgen Biotech for Original Manufacturer Collaboration

1. Strong Manufacturing Capability and Quality Assurance

Hotgen Biotech operates advanced manufacturing facilities, including the new Langfang production base, strictly adhering to international standards.

The company holds ISO 13485 certification, over 90 EU in vitro diagnostic regulation certifications, and extensive global registration qualifications.

Original manufacturer customization services include brand customization, label customization, and performance adjustments to meet specific regulatory and clinical needs.

2. Innovation-Driven Differentiation Advantage

Hotgen Biotech holds over 70 patents and has received national-level honors such as the National Technological Invention Award.

The company continues to increase R&D investment, allowing partners to benefit from proprietary technologies such as upconversion luminescence technology and advanced chemiluminescence magnetic microparticle technology.

The company's recent expansion in cytokine detection and specific diagnostics for tuberculosis and gastric diseases ensures that original equipment manufacturer products stay at the forefront of precision medicine.

3. Global Reach and Mature Experience

Hotgen Biotech's equipment has been deployed in over 50 countries, with more than 18,000 units installed globally.

The company has strategic subsidiaries in Europe, India, and the Americas, and during the pandemic, provided COVID-19 rapid testing products to several continents, demonstrating a reliable supply chain and support capability, which is crucial for the scalable development of original equipment manufacturers.

4. Comprehensive Support for Partners

Original equipment manufacturer collaboration includes not only products but also technical training, regulatory registration support, market support, and after-sales service.

The company's global recruitment of sales and technical engineers also reflects its commitment to long-term cooperative relationships.

Whether it's private-label chemiluminescence analyzers or co-developed test kits, Hotgen Biotech prioritizes mutual success.

5. Cost-Effectiveness and Flexibility

Hotgen Biotech optimizes costs while maintaining high performance.

For example:

• Upconversion luminescence reagents can be stably stored at room temperature

• Chemiluminescence system maintenance costs are low

• Flexible single-sample testing mode

These features enable partners to offer competitive pricing while ensuring high sensitivity and specificity, especially suitable for large-scale screening and emerging markets.

Practical Applications and Clinical Impact

Infectious Diseases

Advanced tuberculosis infection detection technology combined with single-sample chemiluminescence or upconversion luminescence platforms achieves latent and active infection detection with reduced interference.

Tumor and Gastrointestinal Diseases

The gastric marker combination (gastrin 17, pepsinogen I/II, Helicobacter pylori) can be used for:

• Early risk stratification

• Cancer monitoring

Inflammation and Cytokines

A comprehensive detection panel supports:

• Sepsis

• Autoimmune diseases

• Critical care diagnostics

and provides rapid automated results.

Hormones and Chronic Diseases

Including:

• Thyroid testing

• Reproductive hormone testing

• Cardiac testing

• Diabetes testing

These applications bring real value: faster turnaround times, more accurate results, lower workload, and better patient outcomes, advantages that original equipment manufacturers can promote under their own brands.

Strategic Advantages of Collaborating with Hotgen Biotech as an Original Manufacturer

In the highly competitive, cost-intensive, and tightly regulated in vitro diagnostics market, collaborating with Hotgen Biotech offers strategic advantages.

Distributors and manufacturers can:

• Rapidly expand product portfolios using mature certified products

• Access customizable equipment without significant R&D investment

• Leverage scale advantages for stable supply and competitive pricing

• Benefit from continuous innovation, ensuring long-term technological advancement

Hotgen Biotech's listing on the Shanghai Stock Exchange Sci-Tech Innovation Board also reflects its financial stability and long-term strategic vision, providing assurance for collaboration.

Join Hotgen Biotech's Original Manufacturer Collaboration Network

With the aging population, the threat of infectious diseases, and the development of precision medicine, the demand for accessible high-quality diagnostics is continuously growing.

Hotgen Biotech invites forward-looking enterprises to explore original equipment manufacturer collaboration opportunities.

Whether you need:

• Fully automated chemiluminescence immunoassay analyzer supply

• Upconversion luminescence point-of-care testing equipment

• Complete in vitro diagnostic system integration

Hotgen Biotech can provide solutions.

We welcome you to contact the Hotgen Biotech team to discuss customized cooperation models.

Collaborating with Hotgen Biotech, you gain not just products but a trusted partner committed to advancing global diagnostic innovation.

Hotgen Biotech: Empowering partners to provide life-changing precision diagnostic solutions. Building a healthier future together.